William Gassen, a director at Oscar Health, Inc., has acquired 698 deferred stock units, according to a recent SEC filing.
This acquisition, reported on October 13, 2026, is significant as it shows Gassen's ongoing commitment to the company and its future prospects. The transaction occurred on October 8, 2026, at a price of $33.10 per share, which reflects the closing price of Oscar Health's Class A common stock on that date.
Background
Oscar Health, Inc. is a company that operates in the hospital and medical service plans sector, classified under the SIC code 6324. The company has been publicly traded and is known for its innovative approach to health insurance. Gassen's recent filing is part of a series of disclosures, with the last several filings being Form 4 submissions.
What the Filing Says
The filing states, "The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors." This indicates that Gassen has opted for stock units instead of cash, suggesting a strong belief in the company's value.
Impact
This acquisition may affect other shareholders and potential investors by reinforcing confidence in Oscar Health's direction. As a director, Gassen's actions are closely watched, and this move could influence how others view their investments in the company.
What's Next
The filing does not say what happens next.